The rule of thumb in the pharmaceuticals industry is that it takes a decade to go “from molecule to market”. In fact, it often takes as long as 16 years and plenty of money is spent over that time, including on the 10,000 or so compounds that fail for each drug that becomes a success. In a rare acquisition of a Chinese company involved in research and development, Charles River Laboratories is buying Wuxi Pharma Tech for $1.6bn in cash and stock to capture a bigger slice of that expenditure.
制药业的经验之谈是：从“分子到市场”要花费10年的时间。事实上，这段过程往往要花费16年，而且其间要投入大量金钱，包括在每种药物获得成功之前失败的那1万多种化合物上的投入。在一笔颇为罕见的针对manbetx3.0 药品研发企业的交易中，Charles River Laboratories以16亿美元的现金加股票形式收购了无锡药明康德(WuXi AppTec)，希望能够借此节省一大笔这类支出。
您已阅读25%（684字），剩余75%（2045字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。